Details for 2020212556
Up to date per 01.04.2026
Actions
Details for 2020212556
Granted/Registered
European Patent
14.07.2021 A
29.05.2024 B1
20.10.2014
US
201462066280 P
07.01.2015
US
201562100844 P
A61K 31/439 20060101AFI20210521BHEP
Owner
Oyster Point Pharma, Inc.202 Carnegie Center, Suite 109 Princeton, New Jersey 08540US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
ACKERMANN, Douglas Michael, Jr.341 Crestmont Drive San Francisco, CA California 94131US
LOUDIN, James203 Kilts Drive Houston, TX Texas 77024US
MANDELL, Kenneth J.147 Lowell Street Arlington, MA Massachusetts 02474US
Information about Fees